About Jason Coloma
Form D filings for EpiBiologics in 2024 list Jason Coloma as director.
Jason Coloma first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jason Coloma in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jason Coloma works with at each company, as listed on that company's latest Form D.
EpiBiologics, Inc. · Form D/A, Apr 25, 2024
AK
Ann Lee-Karlon
CEO and director
SB
Samuel Bjork
Director
Alexandra Cantley
Director
MM
Mitchell Mutz
Executive officer and director
SM
Seiji Miyahara
Director
JW
James Wells
Director